The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaxCyte Regulatory News (MXCT)

Share Price Information for MaxCyte (MXCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 365.00
Bid: 360.00
Ask: 370.00
Change: -2.00 (-0.54%)
Spread: 10.00 (2.778%)
Open: 365.00
High: 365.00
Low: 365.00
Prev. Close: 367.00
MXCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holdings in Company

6 Oct 2021 07:00

RNS Number : 1277O
MaxCyte, Inc.
06 October 2021
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

US57777K1060

Issuer Name

MAXCYTE, INC.

UK or Non-UK Issuer

Non-UK

2. Reason for Notification

An acquisition or disposal of voting rights; An acquisition or disposal of financial instruments

3. Details of person subject to the notification obligation

Name

Vitruvian Partners LLP

City of registered office (if applicable)

London

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Name

City of registered office

Country of registered office

Life Tech S.à r.l.

Luxembourg

Luxembourg

5. Date on which the threshold was crossed or reached

24-Sep-2021

6. Date on which Issuer notified

28-Sep-2021

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

3.110000

0.000000

3.110000

3122500

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

US57777K1060

3122500

3.110000

Sub Total 8.A

3122500

3.110000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

- The Vitruvian Investment Partnership III is managed by Vitruvian Partners LLP and isd eemed to be the ultimate beneficial owner of Life Tech S.à r.l.- The voting rights attached to shares disclosed herein - 3,122,500, equivalent to 3.11% of issuer's voting rights - are comprised by 2,222,500 LSE (AIM) listed shares (LSE SEDOL: BYVJZ42) and by 900,000 US NASDAQ listed shares (NASDAQ: SEDOL BKMQF66).

12. Date of Completion

28-Sep-2021

13. Place Of Completion

London

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLDKPBBKBDBFKK
Date   Source Headline
5th Sep 20231:05 pmRNSBaird Global Healthcare Conference Participation
4th Sep 20231:32 pmRNSTR-1: Notification of major holdings
4th Sep 20237:00 amRNSTotal Voting Rights
1st Sep 20239:01 amRNSExercise of options and PDMR dealing
18th Aug 20235:25 pmRNSTR-1
17th Aug 20234:27 pmRNSTR-1: Notification of major holdings
17th Aug 20237:00 amRNSTR-1: Notification of Major Holdings
10th Aug 20237:25 amRNSFiling of Form 10-Q
10th Aug 20237:00 amRNSSecond Quarter and Half-Year Results
8th Aug 20233:15 pmRNSTR-1: Notification of major holdings
7th Aug 20235:01 pmRNSTotal Voting Rights and Block Listing Return
1st Aug 20231:05 pmRNSStrategic Platform License with Prime Medicine
31st Jul 20235:26 pmRNSExercise of options and PDMR dealing
26th Jul 20232:31 pmRNSTR-1: Notification of major holdings
24th Jul 20235:08 pmRNSTR-1: Notification of major holdings
24th Jul 20235:06 pmRNSTR-1: Notification of major holdings
13th Jul 20231:05 pmRNSNotice of Second Quarter 2023 Financial Results
11th Jul 20237:00 amRNSTR-1: Notification of major holdings
10th Jul 20231:05 pmRNSSigning of Strategic Platform License
10th Jul 20237:00 amRNSTR-1: Notification of major holdings
7th Jul 20239:23 amRNSTotal Voting Rights
6th Jul 20234:41 pmRNSTR-1: Notification of major holdings
6th Jul 20231:05 pmRNSSigning of Strategic Platform License
29th Jun 20233:19 pmRNSTR-1: Notification of major holdings
29th Jun 20237:00 amRNSTR-1: Notification of major holdings
29th Jun 20237:00 amRNSExercise of options and PDMR dealing
23rd Jun 20233:46 pmRNSGrant of Options
23rd Jun 20237:17 amRNSResult of AGM
23rd Jun 20237:00 amRNSResult of AGM
21st Jun 202310:10 amRNSPublication of Annual Report
16th Jun 202312:32 pmRNSExercise of options and PDMR dealing
2nd Jun 20237:00 amRNSUpcoming Investor Conferences
1st Jun 20237:00 amRNSTotal Voting Rights
11th May 20237:22 amRNSFiling of Form 10-Q
11th May 20237:00 amRNSFirst Quarter Financial Results
9th May 20237:00 amRNSExercise of options and PDMR dealing
4th May 20231:05 pmRNSSigning of Strategic Platform License
3rd May 20234:22 pmRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSNotice of First Quarter 2023 Financial Results
30th Mar 202312:46 pmRNSDirector/PDMR Shareholding
28th Mar 20237:00 amRNSAppointment of Chief Financial Officer
22nd Mar 20237:00 amRNSGrant of Options and PDMR Dealing
16th Mar 20237:01 amRNSFiling of Form 10-K
16th Mar 20237:00 amRNS2022 Full Year Results
8th Mar 20231:00 pmRNSEstablishment of New Scientific Advisory Board
7th Mar 20237:00 amRNSPreliminary Unaudited Q4 &FY 2022 Revenue Results
6th Feb 20233:40 pmRNSDirector/PDMR Shareholding
2nd Feb 20237:00 amRNSNotice of Results
30th Jan 20237:00 amRNSExercise of options and PDMR dealing
4th Jan 20237:00 amRNSSigning of Strategic Platform License

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.